MedTrace Logo

Rapid HIV Viral Load Monitoring in High Risk Patients In Uganda

NCT03553693 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2443

Last updated 2021-03-30

No results posted yet for this study

Summary

The RAPID-VL study will take place in 20 HIV care health facilities in Southwestern Uganda. The study will test the hypothesis that a multi-component intervention package that targets barriers to efficient and timely HIV viral load (VL) testing will improve test ordering, speed up result turnaround times, and improve the quality of VL results counseling to patients. Phase 1 of the study will consist of a 1-year retrospective medical record review in all participating health facilities. In Phase 2 the intervention will be introduced in 10 randomly chosen health facilities, while the remaining 10 sites will continue with standard VL testing and counseling operations. The study will measure the speed and efficiency of VL testing, experiences of patients and clinicians with the intervention, and the cost of the intervention.

Conditions

Interventions

OTHER

RAPID-VL study intervention

* Viral load (VL) ordering flowsheet with periodic health facility performance feedback * Rapid near-point-of-care VL testing and telephone delivery of results * Structured VL counseling package

Sponsors & Collaborators

Principal Investigators

  • Vivek Jain, MD, MAS · University of California, San Francisco

  • Moses R Kamya, MBChB, MMed · Makerere University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-16
Primary Completion
2020-11-16
Completion
2020-11-16

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03553693 on ClinicalTrials.gov